-
EP3800189
European procedure
Extract from the Register of European Patents
EP About this file: EP3800189
| EP3800189 - PREPARATION OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 03.05.2024 Database last updated on 16.11.2024 | |
| Former | The patent has been granted Status updated on 26.05.2023 | ||
| Former | Grant of patent is intended Status updated on 19.01.2023 | ||
| Former | Request for examination was made Status updated on 01.10.2021 | ||
| Former | The application has been published Status updated on 05.03.2021 | Most recent event Tooltip | 03.05.2024 | No opposition filed within time limit | published on 05.06.2024 [2024/23] | Applicant(s) | For all designated states Loxo Oncology, Inc. 281 Tresser Boulevard 9th Floor Stamford, Connecticut 06901 / US | For all designated states Array Biopharma, Inc. 3200 Walnut Street Boulder, CO 80301 / US | [2021/14] | Inventor(s) | 01 /
REYNOLDS, Mark Loxo Oncology, Inc. 281 Tresser Blvd. Stamford, CT 06901 / US | 02 /
EARY, Charles Todd Loxo Oncology, Inc. 281 Tresser Blvd. Stamford, CT 06901 / US | 03 /
SPENCER, Stacey 873 Stagecoach Trail Lyons, CO 80540 / US | 04 /
JUENGST, Derrick 4529 Canterbury Drive Boulder, CO 80301 / US | 05 /
HACHE, Bruno Loxo Oncology, Inc. 281 Tresser Blvd. Stamford, CT 06901 / US | 06 /
JIANG, Yutong Array Biopharma Inc. 3200 Walnut Street Boulder, CO 80301 / US | 07 /
HAAS, Julia Array Biopharma Inc. 3200 Walnut Street Boulder, CO 80301 / US | 08 /
ANDREWS, Steven W. Array Biopharma Inc. 3200 Walnut Street Boulder, CO 80301 / US | [2021/14] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [2023/26] |
| Former [2021/14] | HGF 1 City Walk Leeds LS11 9DX / GB | Application number, filing date | 20208218.6 | 18.05.2017 | [2021/14] | Priority number, date | US201662338359P | 18.05.2016 Original published format: US 201662338359 P | [2021/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3800189 | Date: | 07.04.2021 | Language: | EN | [2021/14] | Type: | B1 Patent specification | No.: | EP3800189 | Date: | 28.06.2023 | Language: | EN | [2023/26] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 10.12.2020 | Classification | IPC: | C07D487/04, A61K31/5025, A61P35/00, A61P43/00 | [2021/14] | CPC: |
C07D487/04 (EP,IL,KR,RU,US);
A61K31/519 (IL,KR,RU);
A61P35/00 (EP,KR,RU);
A61P43/00 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/44] |
| Former [2021/14] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | HERSTELLUNG VON (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE | [2023/03] | English: | PREPARATION OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE | [2021/14] | French: | PRÉPARATION DE (S)-N-(5-((R)-2-(2,5-DIFLUOROPHÉNYL)PYRROLIDIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE | [2023/03] |
| Former [2021/14] | VERFAHREN ZUR HERSTELLUNG VON (S)-N-(5-((R)-2-(2,5-DIFLUORPHENYL)PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDIN-1-CARBOXAMID UND DESSEN SALZEN | ||
| Former [2021/14] | PROCÉDÉ DE PRÉPARATION DE (S)-N-(5-((R)-2-(2,5-DIFLUOROPHÉNYL)PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE -1-CARBOXAMIDE ET DE SES SELS | Examination procedure | 27.09.2021 | Amendment by applicant (claims and/or description) | 27.09.2021 | Examination requested [2021/44] | 27.09.2021 | Date on which the examining division has become responsible | 20.01.2023 | Communication of intention to grant the patent | 19.05.2023 | Fee for grant paid | 19.05.2023 | Fee for publishing/printing paid | 19.05.2023 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP17726442.1 / EP3458456 | Opposition(s) | 02.04.2024 | No opposition filed within time limit [2024/23] | Fees paid | Renewal fee | 17.11.2020 | Renewal fee patent year 03 | 17.11.2020 | Renewal fee patent year 04 | 13.05.2021 | Renewal fee patent year 05 | 14.03.2022 | Renewal fee patent year 06 | 14.03.2023 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | SM | 28.06.2023 | GR | 29.09.2023 | [2024/08] |
| Former [2023/50] | GR | 29.09.2023 | Documents cited: | Search | [AD]WO2010048314 (ARRAY BIOPHARMA INC [US], et al) [AD] 1-12 * page 59 - page 60; examples 14,14A *; | [XDPI]WO2016077841 (ARRAY BIOPHARMA INC [US], et al) [XDP] 1,5-12 * page 57 - page 65 * * scheme 1 *[I] 1-12 | by applicant | WO2010048314 | - REVISED AND EXPANDED, Pharmaceutical Dosage Forms: Parenteral Medications, American Pharmaceutical association and the Pharmaceutical Society of Great Britain, vol. 1-2 |